TP53 and breast cancer: It also provided an explanation to the fact that majority of basal-like BC (included into the TNBC subtype) (144) with mutated p53 exhibits complete response to chemotherapy, while the luminal subtype retaining WT p53 is somewhat chemoresistant (18, 145).